Cargando…

Validation of diagnostic ICHD-3 criteria for menstrual migraine

OBJECTIVE: To assess validity of ICHD-3 diagnostic criteria for menstrual migraine. METHODS: We performed a longitudinal E-diary study in premenopausal women with migraine. Menstrual migraine diagnosis was self-reported at baseline, and verified according to diary based ICHD-3 criteria and a previou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verhagen, Iris E, Spaink, Hermes AJ, van der Arend, Britt WH, van Casteren, Daphne S, MaassenVanDenBrink, Antoinette, Terwindt, Gisela M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535967/ https://www.ncbi.nlm.nih.gov/pubmed/35514214 http://dx.doi.org/10.1177/03331024221099031

Ejemplares similares

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary
por: van Casteren, Daphne S., et al.
Publicado: (2021)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

E-diary use in clinical headache practice: A prospective observational study
por: van Casteren, Daphne S, et al.
Publicado: (2021)

Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study
por: Verhagen, Iris E, et al.
Publicado: (2021)

Serum CGRP in migraine patients using erenumab as preventive treatment
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2021)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Field testing of the ICHD-3β and expert opinion criteria for chronic migraine
por: Jiang, Huahua, et al.
Publicado: (2016)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2021)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families
por: Häppölä, Paavo, et al.
Publicado: (2021)

ICHD-3 is significantly more specific than ICHD-3 beta for diagnosis of migraine with aura and with typical aura
por: Göbel, Carl H., et al.
Publicado: (2020)

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse
por: van Hoogstraten, Willem Sebastiaan, et al.
Publicado: (2019)

Sex Differences in Risk Profile, Stroke Cause and Outcome in Ischemic Stroke Patients With and Without Migraine
por: Linstra, Katie M., et al.
Publicado: (2021)

Measurements of 17β-estradiol levels in mice for migraine research
por: Chan, K, et al.
Publicado: (2013)

Application of ICHD-II Criteria in a Headache Clinic of China
por: Dong, Zhao, et al.
Publicado: (2012)

Decreasing the minimal duration of the attack to 1 hour: is this sufficient to increase the sensitivity of the ICHD-II diagnostic criteria for migraine in childhood?
por: Arruda, Marco A., et al.
Publicado: (2004)

17β-estradiol and methylation of migraine-related genes
por: Labruijere, S, et al.
Publicado: (2013)

Cardiac cephalalgia: a narrative review and ICHD-3 criteria evaluation
por: Navarro-Pérez, María Pilar, et al.
Publicado: (2022)

Sleep apnoea headache in obstructive sleep apnoea syndrome patients presenting with morning headache: comparison of the ICHD-2 and ICHD-3 beta criteria
por: Suzuki, Keisuke, et al.
Publicado: (2015)

Frequency of migraine according to the ICHD-3 criteria and its association with sociodemographic and triggering factors in Pakistan: A cross-sectional study
por: Athar, Farwa, et al.
Publicado: (2022)

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
por: Haanes, Kristian Agmund, et al.
Publicado: (2016)

Methylation of Migraine-Related Genes in Different Tissues of the Rat
por: Labruijere, Sieneke, et al.
Publicado: (2014)

Protective effects of PACAP in ischemia
por: Reglodi, Dora, et al.
Publicado: (2018)

Headache medication and the COVID-19 pandemic
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2020)

Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate?
por: Sacco, Simona, et al.
Publicado: (2010)

Features of Primary Chronic Headache in Children and Adolescents and Validity of Ichd 3 Criteria
por: Papetti, Laura, et al.
Publicado: (2019)

Experts’ opinion about the pediatric secondary headaches diagnostic criteria of the ICHD-3 beta
por: Özge, Aynur, et al.
Publicado: (2017)

Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria
por: Moavero, Romina, et al.
Publicado: (2018)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Could erectile dysfunction be a side effect of CGRP inhibition? A case report
por: Al-Hassany, Linda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d6mg0srll8f7pda8k8k325s3r3